Print ISSN:-2249-8176

Online ISSN:-2348-7682

CODEN : PJMSD7

Current Issue

Year 2024

Volume: 14 , Issue: 2

  • Article highlights
  • Article tables
  • Article images

Article Access statistics

Viewed: 377

Emailed: 0

PDF Downloaded: 543


Saloni: Increasing BMI is a risk factor for developing pre diabetes hyperglycemia and Diabetes


Introduction

Obesity is increasing at an alarming rate throughout the world. Several studies in India have shown that changes in dietary patterns, physical activity level are related to increasing frequencies of obesity. The role of vitamin fortification leading to obesity is becoming more prevalent in recent days.1 In obesity as excessive adipose tissue accumulates, an al­tered metabolic profile occurs along with a variety of adapta­tions and alterations in cardiovascular structure and function even in the absence of co-morbidities. Studies indicate that the presence of obesity increases the risk for developing diabetes and cardiovascular diseases.2

Adipose tissue excess or obesity, particularly in the visceral compartment, is associated with insulin resistance, hyperg­lycemia, dyslipidemia. hypertension, and prothrombotic and proinflammatory states. The most common cause of insulin resistance occurs when energy intake exceeds the metabolic rate leading to obesity.3

Type II diabetes mellitus is strongly associated with over­weight in both genders in all ethnic groups.4

Men and women with a BMI of 25.0 to 29.9 kg/m2 are considered overweight, and those with a BMI 30 kg/m2 or greater are considered obese. The prevalence of obesity - related diseases, such as diabetes, begins to increase at BMI values around 25 kg/m2. Obese persons with excess abdominal fat are at higher risk for diabetes, hypertension, dyslipidemia, and ischemic heart disease than obese persons whose fat is located predominant­ly in the lower body.5

In obese adults, type 2 diabetes develops over a long period, and impaired glucose tolerance can be a predictor for the risk of development of diabetes and cardiovascular disease. 6

FBS < 100 mg/dl is considered normal and between 100–125 mg/dl along with Hb A1C 5.7%-6.4% is marked as impaired fasting glucose or prediabetes. FBS≥ 126 mg/dl along with Hb A1C ≥6.5% is defined as diabetes mellitus.7

Prediabetic hyperglycemia -fast­ing plasma glucose of 110 to 125 mg/dl confers an increased risk for cardiovascular disease.8

The prevalence of diabetes and prediabetes are known to relate with higher ranger of waist circumference, waist /hip ratio and body mass index.9

Aims and Objectives

To study the relation be­tween BMI and fasting blood sugar.

Materials and Methods

The subjects for the study were 200 in the age group of 21 to 40 years. Control group of 100 patients had BMI of 18-24 kg/m2 and study group of 100 patients had BMI of 25-29kg/m2. Height and weight were recorded.

Study group excluded people on treatment for diabetes mel­litus and cardiovascular diseases.

BMI was calculated from the following equation

Body Mass Index (kg/m2) = Weight in Kg

Height in m2

The Body Mass Index value ranging between 18.5 -25.0 is considered as normal, < 18.5 indicates the status as under­nourished, while value above 25 as overweight and above 30.0 as obese.

Biochemical analysis

The patient was asked to fast over­night for 8-10 hours. Fasting Blood Sugar was estimated by Glucose Oxidase method.

Results

Table 1

Comparison of BMI with fasting blood sugar

BMIkg/m2

FBS <11O mg/dl

FBS 110-125mg/dl

FBS >126 mg/dl

<25

75

20

5

>25

25

50

25

75% of overweight patients had FBS>110 mg/dl whereas 25% of normal weight patients had FBS>110 mg/dl.

Prediabetic hyperglycemia was noted in 50% of overweight patients.

Diabetes was diagnosed in 25% of overweight patients.

Discussion

Diabetes mellitus is one of the leading risk factors of Coro­nary Artery Disease and is growing in developing countries because of the changes in lifestyles, increasing high-calorie diet and physical inactivity.10

All stages of glucose abnormalities like prediabetes and established diabetes mellitus are associated with CAD and detection of these abnormalities is of great value in early screening of cardiovascular diseases.11, 12

Resistin is an ad­ipokine secreted from adipose tissue and monocytes. It is named for its ability to resist or interfere with insulin action It was proposed as a link between obesity and diabetes.13, 14

In obese individuals, adipose tissue releases increased amounts of non-esterified fatty acids, glycerol, hormones, pro-inflammatory cytokines and other factors that are in­volved in the development of insulin resistance.15

Our study is done to re-establish the direct relationship be­tween increased body weight and fasting blood sugar.

In the control group of BMI <25, majority of people showed fasting blood sugar of less than 100mg/dl.In the study group with BMI>25, majority of people showed FBS >100mg/dl As we have excluded patients of dia­betes mellitus and cardiovascular diseases in our study, other causes for the increased FBS leading to prediabetes, like the role of stress in daily life should be considered. Stress hor­mones are known to increase blood glucose levels. Physical and emotional stress increases these hormones thereby in­creasing blood glucose levels.

Measures should be taken by the prediabetics to keep the sugar levels normal from reaching diabetic levels by chang­ing the lifestyle, increasing physical activity, consuming food having low glycemic index with high fiber content and frequent monitoring of blood glucose levels along with HbA1c.

Prediabetic state is a ‘grey zone’ which implies a declining glucose homeostatic efficiency. Though only 25% of cases progress to full blown T2DM, when combined with obesity (BMI >25), it is a definite predictor of onset of T2DM in due course. Moreover, complications particularly cardiovascular abnormalities begin in prediabetic phase surreptitiously even before overt Diabetes is medically diagnosed

Conclusion

The existence of a significant direct correlation between FBSand BMI was confirmed in the present study. Our results therefore suggest that a low BMI is important for maintain­ing normal blood glucose levels.

This study highlights the critical importance of early inter­vention directed at treatment of obesity in association with normal blood glucose levels to avert the long-term conse­quences of obesity and diabetes mellitus on the development of various complications

Source of Funding

No financial support was received for the work within this manuscript.

Conflict of Interest

The authors declare they have no conflict of interest.

References

1 

SS Zhou Y Zhou Excess vitamin intake: An unrec­ognized risk factor for obesityWorld J Diabetes2014155113

2 

PA Cassano MR Segal PS Vokonas ST Weiss Body fat distribution, blood pressure, and hypertensionAnn Epidomol19901334810.1016/1047-2797(90)90017-m

3 

D. L. Nelson M. C. Cox W. H. Freeman Lehninger: principles of biochemistry4th Edn.Co., New York20041119

4 

G A Colditz W C Willett A Rotintzky J E Manson Weight gain as a risk factor for clinical diabetes mellitus in womenAnn Intern Med19951224816

5 

AH Kissebah N Videlingum R Murray Relation of Body Fat Distribution to Metabolic Complications of Obesity*J Chin /endoccrinol Metab 19825422546010.1210/jcem-54-2-254

6 

R Sinha G Fish B Teagu Tamborlan Wv B Banyas K Allen Prevalence of impaired glucose tolerance test among children and adolescents with marked obesityN Engl J Med200234680210

7 

American Diabetes AssociationStand Med Care Diabetes2015381193

8 

YS Levitzky MJ Pencina RB D’Agostino JB Meigs JM Murabito RS Vasan Impact of Impaired Fasting Glucose on Cardiovascular DiseaseJ Am Coll Cardiol20085132647010.1016/j.jacc.2007.09.038

9 

F Azizi A Esmaillzadeh P Mirmiran E Ainy Is there an independent association between waist-to-hip ratio and cardiovascular risk factors in overweight and obese women?Int J Cardiol20051011394610.1016/j.ijcard.2004.03.011

10 

M Sadeghi H Roohafza Diabetes and associ­ated cardiovascular risk factors in iran: The isfahan healthy heart programmeAnn Acad Med20073617580

11 

LG Mellbin M Anselmino R Lars Diabetes, prediabetes and cardiovascular riskEur J Cardiovasc Prev Rehabil2010171_suppls9s1410.1097/01.hjr.0000368192.24732.2f

12 

O Schnell The Links between Diabetes and Cardiovascular DiseaseJ Interv Cardio 2005186413610.1111/j.1540-8183.2005.00080.x

13 

CM Steppan ST Bailey S Bhat EJ Brown RR Banerjee CM Wright The hormone resistin links obesity to diabetesNat200140968183071210.1038/35053000

14 

D B Savage Ge C P Sewter E S Klenk Resistin/ Fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor-gamma action in hu­mansDiabetes2001502199202

15 

SE Kahn RL Hull KM Utzschneider Mechanisms linking obesity to insulin resistance and type 2 diabetesNat2006444840610.1038/nature05482



jats-html.xsl

© 2020 Published by Innovative Publication Creative Commons Attribution 4.0 International License (creativecommons.org)